Gritstone bio, Inc. (GRTS) earnings
Quarterly and annual GRTS reports and results, each read against the price at its own news timestamp. Back to the GRTS overview →
8 measured GRTS earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Gritstone bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.33% | -5.46% | |
| Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates | Press release | -2.33% | -5.46% | |
| Form 10-Q Gritstone bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.65% | -7.72% | |
| Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates | Press release | +0.65% | -7.72% | |
| Gritstone bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024 | Press release | -0.62% | +6.42% | |
| Form 10-K Gritstone bio, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.96% | +1.40% | |
| Form 10-Q Gritstone bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.81% | -6.02% | |
| Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates | Press release | -1.81% | -6.02% |
Keep exploring
More GRTS: analyst actions → · SEC filings → · GRTS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Brainstorm Cell Therapeutics Inc. (BCLI) | 660 | 0.00% | 47% |
| OPHTHOTECH CORP COMMON (OPHT) | 660 | -0.20% | 43% |
| Inovio Pharmaceuticals, Inc. (INO) | 658 | -0.29% | 43% |
| VistaGen Therapeutics, Inc. (VTGN) | 658 | +0.16% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.